Waters is trading at $462.72, down 4.06%, with broader market weakness the likeliest context for the decline.
- No clear company-specific announcement on October 30 explains the drop; Waters’ next scheduled earnings report is November 3.
- The S&P 500 fell 1.71% and Nasdaq fell 2.84%.
- Healthcare rose 2.32% in the regular session, so sector strength does not explain Waters’ decline.